July 05, 2008
Rutgers University Department of Biomedical Engineering
Message from the Dean

The bar of success is set high for the School of Engineering at Rutgers. Simply put, our goal is to become one of the top ten engineering schools in the country. Achieving this goal of growth and excellence requires innovative strategic planning and the investment of new resources. Leading the charge is the Department of Biomedical Engineering which, over the past five years, has: i) established a new vibrant undergraduate program which is currently the third-most popular engineering major; ii) more than doubled its core faculty; and iii) more than quadrupled its external research funding. Internally, we are dedicating a significant amount of resources to this effort, and have already assembled a number of key ingredients for success. These include visionary leadership, new state-of-the-art facilities, and exciting and unique programs in tissue engineering, nanotechnology, functional genomics, and biomedical imaging. Finally, industry in New Jersey, which is #1 in pharmaceutical development and #3 in medical device development, is more than ever looking to us for outstanding recruits and new discoveries. With quality as the foundation to our growth, we are poised to meet this demand head-on by sculpting a unique and outstanding biomedical engineering enterprise with rigor and relevance as its guiding principles.


Michael T. Klein,
Dean, School of Engineering,
Rutgers, The State University of New Jersey

Contribute
Contribute to Biomedical Engineering at Rutgers.

Click here for more information.
Login
Login:

Password:

Latest News
Li Cai Awarded Busch Biomedical Research Grant
July 01, 2008
Li Cai received a two year $50,000 Busch Biomedical Research Grant to support his research on "Control of CD44 Expression in Breast Cancer Stem Cells". The project is to study the transcription regulation of breast cancer stem cells.

Annual Review of Biomedical Engineering Ranked No. 1 again by ISI
June 23, 2008
For the sixth year in a row, articles in the Annual Review of Biomedical Engineering (ARBME) were cited more often than papers in any of its peer journals, according to ISI's 2007 Journal Citation Report, giving it the highest "impact factor" in its peer group. The ARBME had an impact factor of 11.567 placing it #1 in its peer group of 44 journals, and #2 among all engineering journals. Professor Martin Yarmush serves as the editor-in-chief of the ARBME which published its first volume in 1999.

John Semmlow awarded $750,000 NIH-NIHLB Grant
June 13, 2008
John Semmlow and SonoMedica, Inc. of McClean, VA were awarded a Phase II STTR grant of $750,000 from the NIH-NIHLB over two years to advance his work on detection of coronary artery disease using acoustic information.

Anant Madabhushi awarded $260,000 Wallace H. Coulter Grant
June 11, 2008
Anant Madabhushi has been awarded a 2 year Phase 2 grant for $260,000 from the Wallace H. Coulter foundation for his proposal entitled "Automated Detection of Prostate Cancer from Multi-protocol High Resolution MRI". The Phase 2 award was competitive and of the 25 Phase 1 Early Career awardees only 7 were selected for Phase 2 based on progress made in Phase 1, a new grant application, and an oral presentation in front of a review committee in Florida, in early June. Under the Phase 2 project, Dr. Madabhushi will look to commercialize his ongoing research in developing computerized detection methods for prostate cancer using MRI. Clinical collaborators on this project are Dr. John Tomaszewski, Dr. Mark Rosen, and Dr. Mike Feldman from the University of Pennsylvania.

More News >>

Rutgers, The State University of New Jersey